SCHEMBL6411809

SCHEMBL6411809

FC(F)(F)Oc1ccc(-c2nnc(SCC3CC3)[nH]2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2E1 P05181 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C8 P10632 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2B6 P20813 2/20 0.39
CYP2C19 P33261 2/20 0.39
WNT3A P56704 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
NISCH Q9Y2I1 1/20 0.37
SCN10A Q9Y5Y9 7/20 0.37
KCNH2 Q12809 4/20 0.35
SCN9A Q15858 3/20 0.35
GRIN2B Q13224 1/20 0.35
NPY5R Q15761 1/20 0.34
SCN1A P35498 2/20 0.34
SCN5A Q14524 2/20 0.34
SCN2A Q99250 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404365 0.79 GRK6 (0.40) GRK6WNT3ATNKS2NISCHSCN10A
SCHEMBL6409060 0.78 CYP1A2 (0.56) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6408622 0.78 GRK6 (0.62) GRK6SCN10ASCN9A
SCHEMBL6404070 0.77 SCN9A (0.49) GRK6SCN10ASCN9AMAOB
SCHEMBL16171132 0.77 GRK6 (0.49) GRK6SCN10AKCNH2SCN9ASCN1A
SCHEMBL6405768 0.76 GRK6 (0.38) GRK6WNT3ATNKS2NISCHSCN10A
SCHEMBL6411081 0.72 SCN9A (0.47) GRK6CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL25260119 0.71 SCN10A (0.47) GRK6WNT3ATNKS2NISCHSCN10A
SCHEMBL6406665 0.70 NPY5R (0.42) CYP1A2CYP3A4NPY5RKDM1AMAOB
SCHEMBL10171990 0.69 SCN10A (0.45) GRK6WNT3ATNKS2NISCHSCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT GRK6 3937/4885CYP1A2 93/4885CYP2E1 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.